[Beckwith-Wiedemann syndrome].
Kosho
Tomoki
T
Department of Medical Genetics, Shinshu University School of Medicine.
Fukushima
Yoshimitsu
Y
D001506:Beckwith-Wiedemann Syndrome / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000628:therapy; D050761:Cyclin-Dependent Kinase Inhibitor p57 / Q000235:genetics; D003937:Diagnosis, Differential; D005799:Genes, Dominant; D005817:Genetic Counseling; D018392:Genomic Imprinting / Q000235:genetics; D006801:Humans; D007231:Infant, Newborn; D007335:Insulin-Like Growth Factor II; D008565:Membrane Proteins / Q000235:genetics; D015997:Neonatal Screening; D024642:Potassium Channels, Voltage-Gated / Q000235:genetics; D011379:Prognosis; D011506:Proteins / Q000235:genetics
C493964:CDKN1C protein, human; D050761:Cyclin-Dependent Kinase Inhibitor p57; C035170:IGF2 protein, human; C485621:KCNQ1OT1 long non-coding RNA, human; D008565:Membrane Proteins; D024642:Potassium Channels, Voltage-Gated; D011506:Proteins; D007335:Insulin-Like Growth Factor II